v3.25.3
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Operating expenses:        
Research and development $ 1,553 $ 2,151 $ 5,283 $ 8,529
General and administrative 1,180 1,419 3,549 4,853
Total operating expenses 2,733 3,570 8,832 13,382
Loss from operations (2,733) (3,570) (8,832) (13,382)
Other income (expense):        
Interest income 59 48 92 286
Other income, net 3 9 185 9
Net loss $ (2,671) $ (3,513) $ (8,555) $ (13,087)
Loss per share, basic (in dollars per share) $ (0.06) $ (0.25) $ (0.33) $ (0.95)
Loss per share, diluted (in dollars per share) $ (0.06) $ (0.25) $ (0.33) $ (0.95)
Weighted average number of shares of common stock, basic (in shares) 43,042,691 13,804,651 25,796,756 13,742,325
Weighted average number of shares of common stock, diluted (in shares) 43,042,691 13,804,651 25,796,756 13,742,325

Source